GlassScriptPhysician profile
Robert Azizi
NPI 1316101298
$200,445.80
in general payments reported to CMS, 2019-2025
14 companies · $22K in 2025
The $22K reported for 2025 was more than what 93% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,004 · 2020: $245 · 2021: $41K · 2022: $65K · 2023: $39K · 2024: $31K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $88K · Food and Beverage: $3,183 · Travel and Lodging: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $87,916.66 |
| Food and Beverage | $3,183.23 |
| Travel and Lodging | $500.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $195,239.70 | 2021-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac, Bioflo |
| Cardiovascular Systems INC. | $1,983.75 | 2019-2022 | |
| Nevro Corp. | $669.73 | 2023 | Senza |
| Abbott Laboratories | $520.72 | 2021 | |
| Philips North America LLC | $468.70 | 2020-2023 | |
| Organogenesis INC. | $419.38 | 2023-2025 | Puraply, Puraply Wound Matrix |
| Boston Scientific Corporation | $315.46 | 2021-2024 | Therasphere Administration Set, Varithena Administration Pack |
| Bard Peripheral Vascular, INC. | $293.27 | 2019-2022 | |
| Medtronic, INC. | $144.35 | 2021-2023 | Venaseal |
| Janssen Pharmaceuticals, INC | $134.78 | 2021-2022 | |
| Smith+Nephew, INC. | $115.23 | 2024 | Collagenase Santyl |
| Cook Medical LLC | $96.70 | 2019-2020 | |
| Terumo Medical Corporation | $30.21 | 2019 | |
| Integra Lifesciences Corporation | $13.82 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Azizi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.